Originally posted on May 3, 2023 @ 05:14 Renowned molecular biologist and entrepreneur Björn Cochlovius Ph.D. has been appointed Chief Executive Officer of German biotechnology company Eleva, the developer of ‘Bryotechnology’ – a unique process for the moss-based production of complex therapeutic proteins. Cochlovius brings nearly three decades of scientific…
No responses yet